Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

New treatments for seborrheic dermatitis show promise for difficult cases.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Dupilumab users have a higher risk of developing alopecia areata.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Fzd2 is important for skin and hair development through various signaling ways.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Dupilumab may worsen hair loss in patients with alopecia areata.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Itchy keloids on the chest are linked to more nerve fibers and substance P.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Alopecia areata may be linked to atopic diseases like eczema, asthma, and allergies.